Product Code: ETC6174102 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia Antipsychotic Drugs Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia Antipsychotic Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Australia Antipsychotic Drugs Market - Industry Life Cycle |
3.4 Australia Antipsychotic Drugs Market - Porter's Five Forces |
3.5 Australia Antipsychotic Drugs Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Australia Antipsychotic Drugs Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Australia Antipsychotic Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of mental health disorders in Australia |
4.2.2 Growing awareness about mental health and the importance of treatment |
4.2.3 Advancements in drug development and technology |
4.2.4 Government initiatives to improve mental healthcare services |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for antipsychotic drugs |
4.3.2 Side effects and safety concerns associated with antipsychotic medications |
4.3.3 High cost of antipsychotic drugs |
4.3.4 Competition from alternative treatment options such as therapy and counseling |
5 Australia Antipsychotic Drugs Market Trends |
6 Australia Antipsychotic Drugs Market, By Types |
6.1 Australia Antipsychotic Drugs Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Australia Antipsychotic Drugs Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Australia Antipsychotic Drugs Market Revenues & Volume, By First Generation, 2021- 2031F |
6.1.4 Australia Antipsychotic Drugs Market Revenues & Volume, By Second Generation, 2021- 2031F |
6.1.5 Australia Antipsychotic Drugs Market Revenues & Volume, By Third Generation, 2021- 2031F |
6.2 Australia Antipsychotic Drugs Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Australia Antipsychotic Drugs Market Revenues & Volume, By Schizophrenia, 2021- 2031F |
6.2.3 Australia Antipsychotic Drugs Market Revenues & Volume, By Bipolar disorder, 2021- 2031F |
6.2.4 Australia Antipsychotic Drugs Market Revenues & Volume, By Unipolar depression, 2021- 2031F |
6.2.5 Australia Antipsychotic Drugs Market Revenues & Volume, By Dementia, 2021- 2031F |
6.2.6 Australia Antipsychotic Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia Antipsychotic Drugs Market Import-Export Trade Statistics |
7.1 Australia Antipsychotic Drugs Market Export to Major Countries |
7.2 Australia Antipsychotic Drugs Market Imports from Major Countries |
8 Australia Antipsychotic Drugs Market Key Performance Indicators |
8.1 Number of new patients prescribed antipsychotic drugs |
8.2 Percentage of patients with mental health disorders receiving treatment |
8.3 Rate of adoption of new antipsychotic drug formulations |
8.4 Patient adherence and compliance with prescribed antipsychotic regimens |
9 Australia Antipsychotic Drugs Market - Opportunity Assessment |
9.1 Australia Antipsychotic Drugs Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Australia Antipsychotic Drugs Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Australia Antipsychotic Drugs Market - Competitive Landscape |
10.1 Australia Antipsychotic Drugs Market Revenue Share, By Companies, 2024 |
10.2 Australia Antipsychotic Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |